The presence of anti-SRP autoantibodies is associated with a unique spectrum of clinical phenotype called “the anti-SRP syndrome” with significance in diagnosis, management and prognosis of the disease (Targoff, 2000). The gene discussed is UCN2; the disease is Down syndrome.